Cargando…
Antifibrinolytics in the treatment of traumatic brain injury
Traumatic brain injury (TBI) is a leading cause of trauma-related deaths, and pharmacologic interventions to limit intracranial bleeding should improve outcomes. Tranexamic acid reduces mortality in injured patients with major systemic bleeding, but the effects of antifibrinolytic drugs on outcomes...
Autores principales: | Schober, Patrick, Loer, Stephan A., Schwarte, Lothar A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594127/ https://www.ncbi.nlm.nih.gov/pubmed/35900731 http://dx.doi.org/10.1097/ACO.0000000000001171 |
Ejemplares similares
-
Cerebral metabolic derangements following traumatic brain injury
por: Demers-Marcil, Simon, et al.
Publicado: (2022) -
Hyperlactatemia and other perioperative metabolic disturbances in neuroanesthesia
por: Klimek, Markus, et al.
Publicado: (2022) -
Bleeding properties according to surgical sites during pediatric craniotomy: a retrospective study comparing the two stages of epilepsy surgery
por: Lee, Bora, et al.
Publicado: (2020) -
Effects of tranexamic acid on the activity of glutamate transporter EAAT3
por: Shin, Hyun-Jung, et al.
Publicado: (2020) -
Risk factors for postoperative delirium in elderly patients after spinal fusion surgery
por: Choi, Sijin, et al.
Publicado: (2020)